RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021

Rhea-AI Summary

RxSight, Inc. (NASDAQ: RXST) has rescheduled its second quarter 2021 financial results announcement to September 9, 2021, after market close, in respect of the Rosh Hashanah holiday. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET that same day, open to investors via a live and archived webcast. RxSight specializes in ophthalmic devices, offering the first customizable intraocular lens technology aimed at enhancing post-cataract surgery visual acuity, now featuring ActivShield™ technology for added UV protection.

Positive

• Rescheduled earnings call allows for investor participation after Rosh Hashanah.
• RxSight offers innovative intraocular lens technology with customizable features.
• Introduction of ActivShield™ technology adds value to the product line.

Negative

• None.

ALISO VIEJO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company, today announced an updated date for reporting second quarter 2021 financial results. In observance of the Rosh Hashanah holiday, the company will now report after the market close on Thursday, September 9, 2021. Management will discuss the results during a conference call beginning that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at https://investors.rxsight.com/.

About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens (LAL^®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.

Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
IR@rxsight.com

Company contact:
Roy Freeman
Sr. Director, Marketing
rfreeman@rxsight.com

FAQ

What date will RxSight report its second quarter 2021 financial results?

RxSight will report its second quarter 2021 financial results after market close on September 9, 2021.

What time is the RxSight financial results conference call?

The RxSight conference call will begin at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on September 9, 2021.

How can I listen to RxSight's conference call?

Investors can access the live and archived webcast of RxSight's conference call at their investor relations website.

What is ActivShield™ technology from RxSight?

ActivShield™ technology is a UV protection layer built into RxSight's Light Adjustable Lens, enhancing its functionality.